ARCHIVES

Group Chairmen Reject DCT’s Agenda For Clinical Trials Review, demand Right To Select Speakers

This article is from The Cancer Letter archive.

Vol. 04 No. 26 | June 30, 1978

Download PDF Visit The Full Archive

Related Articles

Biological Modifiers Journal Objects To NEJ Policy, Says It Will OK Clinical Data Release

April 26, 1985

Interferon Alpha-2B Effective For Malignant Melanoma

July 27, 2001

Bushes Restate Commitment to Dialogue

August 8, 2003

Intramural Funding To Decrease, R01s Increase, Klausner Says

September 15, 1995

ACS-Roosevelt Fellows Announced

July 29, 1977

In Brief: HSAs Would Delay NCI Awards By Nine Months; Mary Lasker Names to Carter Health Group

September 17, 1976